# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001485003-24-000005
Filing Date
2024-04-01
Accepted
2024-04-01 08:47:14
Documents
81
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | carm-20231231.htm iXBRL | 10-K | 1884771
2 | EX-10.17 | carm-20231231xexx1017.htm | EX-10.17 | 45134
3 | EX-21.1 | carm-20231231xexx211.htm | EX-21.1 | 3914
4 | EX-23.1 | carm-20231231xexx231.htm | EX-23.1 | 2455
5 | EX-31.1 | carm-20231231xexx311.htm | EX-31.1 | 10663
6 | EX-31.2 | carm-20231231xexx312.htm | EX-31.2 | 10688
7 | EX-32.1 | carm-20231231xexx321.htm | EX-32.1 | 4975
8 | EX-32.2 | carm-20231231xexx322.htm | EX-32.2 | 4998
9 | EX-97 | carm-20231231xexx97.htm | EX-97 | 19159
15 |  | carm-20231231_g1.jpg | GRAPHIC | 709405
| Complete submission text file | 0001485003-24-000005.txt |  | 9421714

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | carm-20231231.xsd | EX-101.SCH | 55617
11 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | carm-20231231_cal.xml | EX-101.CAL | 81166
12 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | carm-20231231_def.xml | EX-101.DEF | 191219
13 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | carm-20231231_lab.xml | EX-101.LAB | 744241
14 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | carm-20231231_pre.xml | EX-101.PRE | 470009
85 | EXTRACTED XBRL INSTANCE DOCUMENT | carm-20231231_htm.xml | XML | 761413

Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36296 | Film No.: 24805767
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)